IBN
Închide

Lista articolelor în limba engleza

Print PDF
Afisarea articolelor: 1-2(2)
2019
1.

A phase 1b study of IMU-131 her2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

. Annals of oncology. 2019, nr. 10(30), 0-0. ISSN 0923-7534 ISSNe 1569-8041. (Cat. )
2.

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: A phase Ib/randomized phase II trial

. Annals of oncology. 2019, nr. 10(30), 1621-1613. ISSN 0923-7534 ISSNe 1569-8041. (Cat. )
 
 

1-2 of 2